Want to see GMAB full AI Analyst Report?
ETFs with Genmab (GMAB) Exposure
The following ETFs maintain exposure to Genmab (GMAB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
33 ETFs Hold Genmab (GMAB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in GMAB |
|---|---|---|---|---|---|---|
| CANC | Tema Oncology ETF | $216.18M | 0.75% | 5.67% | $12.26M | 0.03% |
| NIFE | ― | ― | ― | 5.00% | $113.54K | <0.01% |
| 1FU6 | First Trust NYSE Arca Biotechnology UCITS ETF | $18.87M | 0.63% | 4.89% | $918.61K | <0.01% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | $3.14B | 0.55% | 4.89% | $152.76M | 0.43% |
| GNMX | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | 4.36% | $60.11K | <0.01% |
| AADR | AdvisorShares Dorsey Wright ADR ETF | $35.14M | 1.09% | 3.73% | $1.36M | <0.01% |
| BMED | Future Health ETF | $14.68M | 0.55% | 2.78% | $408.48K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 2.15% | $246.86M | 0.69% |
| CHNA | ― | ― | ― | 1.07% | $39.93K | <0.01% |
| BUYZ | Franklin Disruptive Commerce ETF | $5.36M | 0.50% | 0.93% | $49.13K | <0.01% |
| HELX | Franklin Genomic Advancements ETF | $36.80M | 0.50% | 0.86% | $311.60K | <0.01% |
| WDNA | WisdomTree BioRevolution Fund | $5.18M | 0.45% | 0.75% | $38.06K | <0.01% |
| WDNA | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | 0.73% | $315.55K | <0.01% |
| FHIL | Federated Hermes International Leaders ETF | $3.55M | 0.48% | 0.43% | $15.01K | <0.01% |
| FTQI | First Trust Hedged BuyWrite Income ETF | $1.03B | 0.75% | 0.40% | $4.06M | 0.01% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.35% | $423.33K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.35% | $4.66M | 0.01% |
| AVEU | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | 0.29% | $114.79K | <0.01% |
| CADE | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | 0.20% | $714.90K | <0.01% |
| AVDE | Avantis International Equity ETF | $19.65B | 0.23% | 0.15% | $28.91M | 0.08% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.14% | $1.53M | <0.01% |
| AVSD | Avantis Responsible International Equity ETF | $376.48M | 0.23% | 0.10% | $381.31K | <0.01% |
| JSTC | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | 0.07% | $197.55K | <0.01% |
| AVNC | Avantis All International Core Equity ETF | $99.60M | 0.27% | 0.05% | $49.09K | <0.01% |
| AVIV | Avantis International Large Cap Value ETF | $2.07B | 0.25% | 0.05% | $987.61K | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | 0.04% | $384.08K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | 0.04% | $384.08K | <0.01% |
| FINO | Franklin Innovation Active ETF Trust Units | $8.16M | 0.92% | 0.04% | $15.64K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | 0.01% | $1.49M | <0.01% |
| DFAI | Dimensional International Core Equity Market ETF | $18.27B | 0.18% | <0.01% | $863.17K | <0.01% |
| DFIV | Dimensional International Value ETF | $22.13B | 0.27% | <0.01% | $552.47K | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $49.71K | <0.01% |
| DFIC | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | <0.01% | $103.12K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in GMAB |
|---|---|---|---|---|---|---|
| CANC | 5.67% | Tema Oncology ETF | $216.18M | 0.75% | $12.26M | 0.03% |
| NIFE | 5.00% | ― | ― | ― | $113.54K | <0.01% |
| 1FU6 | 4.89% | First Trust NYSE Arca Biotechnology UCITS ETF | $18.87M | 0.63% | $918.61K | <0.01% |
| FBT | 4.89% | First Trust NYSE Arca Biotechnology Index Fund | $3.14B | 0.55% | $152.76M | 0.43% |
| GNMX | 4.36% | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | $60.11K | <0.01% |
| AADR | 3.73% | AdvisorShares Dorsey Wright ADR ETF | $35.14M | 1.09% | $1.36M | <0.01% |
| BMED | 2.78% | Future Health ETF | $14.68M | 0.55% | $408.48K | <0.01% |
| IBB | 2.15% | iShares Biotechnology ETF | $11.52B | 0.44% | $246.86M | 0.69% |
| CHNA | 1.07% | ― | ― | ― | $39.93K | <0.01% |
| BUYZ | 0.93% | Franklin Disruptive Commerce ETF | $5.36M | 0.50% | $49.13K | <0.01% |
| HELX | 0.86% | Franklin Genomic Advancements ETF | $36.80M | 0.50% | $311.60K | <0.01% |
| WDNA | 0.75% | WisdomTree BioRevolution Fund | $5.18M | 0.45% | $38.06K | <0.01% |
| WDNA | 0.73% | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | $315.55K | <0.01% |
| FHIL | 0.43% | Federated Hermes International Leaders ETF | $3.55M | 0.48% | $15.01K | <0.01% |
| FTQI | 0.40% | First Trust Hedged BuyWrite Income ETF | $1.03B | 0.75% | $4.06M | 0.01% |
| IBBQ | 0.35% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $423.33K | <0.01% |
| OM3E | 0.35% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $4.66M | 0.01% |
| AVEU | 0.29% | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | $114.79K | <0.01% |
| CADE | 0.20% | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | $714.90K | <0.01% |
| AVDE | 0.15% | Avantis International Equity ETF | $19.65B | 0.23% | $28.91M | 0.08% |
| APIE | 0.14% | ActivePassive International Equity ETF | $1.13B | 0.45% | $1.53M | <0.01% |
| AVSD | 0.10% | Avantis Responsible International Equity ETF | $376.48M | 0.23% | $381.31K | <0.01% |
| JSTC | 0.07% | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | $197.55K | <0.01% |
| AVNC | 0.05% | Avantis All International Core Equity ETF | $99.60M | 0.27% | $49.09K | <0.01% |
| AVIV | 0.05% | Avantis International Large Cap Value ETF | $2.07B | 0.25% | $987.61K | <0.01% |
| AVGC | 0.04% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $384.08K | <0.01% |
| AVUS | 0.04% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $384.08K | <0.01% |
| FINO | 0.04% | Franklin Innovation Active ETF Trust Units | $8.16M | 0.92% | $15.64K | <0.01% |
| ONEQ | 0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $1.49M | <0.01% |
| DFAI | <0.01% | Dimensional International Core Equity Market ETF | $18.27B | 0.18% | $863.17K | <0.01% |
| DFIV | <0.01% | Dimensional International Value ETF | $22.13B | 0.27% | $552.47K | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $49.71K | <0.01% |
| DFIC | <0.01% | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | $103.12K | <0.01% |
Popular ETF Comparisons
GMAB ETF Exposure FAQ
What ETFs hold Genmab stock?
Genmab (GMAB) is currently held by 33 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to GMAB include iShares (IBB), First Trust (FBT) and Tema (CANC).
Which ETF has the largest exposure to GMAB?
The ETF with the largest exposure to GMAB is iShares (IBB), with approximately $246.86M in market value exposure.
How much GMAB stock is held by ETFs?
ETFs currently hold approximately $414.83M worth of Genmab (GMAB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.